Skip to main content
. 2020 Oct 28:NEJMoa2029849. doi: 10.1056/NEJMoa2029849

Table 3. Hospitalization.*.

Key Secondary Outcome LY-CoV555 Placebo Incidence
no. of patients/total no. %
Hospitalization 9/143 6.3
700 mg, 1/101 1.0
2800 mg, 2/107 1.9
7000 mg, 2/101 2.0
Pooled doses, 5/309 1.6
*

Data for patients who presented to the emergency department are included in this category.